Journal of the International AIDS Society

Papers
(The TQCC of Journal of the International AIDS Society is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in t135
Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks109
The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study106
The challenge of HIV treatment in an era of polypharmacy100
National trends in HIV pre‐exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 201799
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment99
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?86
Lessons learned from HIV can inform our approach to COVID‐19 stigma86
The time is now: expedited HIV differentiated service delivery during the COVID‐19 pandemic67
Weight gain before and after switch from TDF to TAF in a U.S. cohort study64
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review64
COVID‐19, HIV and key populations: cross‐cutting issues and the need for population‐specific responses52
New pathogen, same disparities: why COVID‐19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic50
Acceleration of differentiated service delivery for HIV treatment in sub‐Saharan Africa during COVID‐1949
SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States49
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial47
Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment45
Multiple forms of discrimination and internalized stigma compromise retention in HIV care among adolescents: findings from a South African cohort43
PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa41
Preventing mental health conditions in adolescents living with HIV: an urgent need for evidence40
Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial40
Missed opportunities to prevent HIV infections among pre‐exposure prophylaxis users: a population‐based mixed methods study, San Francisco, United States39
Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study38
Antiretroviral treatment interruption among people living with HIV during COVID‐19 outbreak in China: a nationwide cross‐sectional study38
Scaling up peer‐led community‐based differentiated support for adolescents living with HIV: keeping the needs of youth peer supporters in mind to sustain success37
Treating depression and improving adherence in HIV care with task‐shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial36
Prevalence and factors associated with common mental disorders in young people living with HIV in sub‐Saharan Africa: a systematic review35
Gendered health institutions: examining the organization of health services and men’s use of HIV testing in Malawi34
Index and targeted community‐based testing to optimize HIV case finding and ART linkage among men in Zambia33
Increasing awareness of HIV pre‐exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta‐analysis of global data33
Current approaches to HIV vaccine development: a narrative review33
Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa32
The impact of COVID‐19 on multi‐month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR‐supported countries: a multi‐country analysis32
Combating HIV stigma in low‐ and middle‐income healthcare settings: a scoping review32
I just believe there is a risk” understanding of undetectable equals untransmissible (U = U) among health providers and HIV‐negative partners in serodiscordant relationships in Kenya32
Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa31
An implementation study of oral and blood‐based HIV self‐testing and linkage to care among men in rural and peri‐urban KwaZulu‐Natal, South Africa31
Population‐wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis31
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription30
Declining HIV incidence in sub‐Saharan Africa: a systematic review and meta‐analysis of empiric data29
HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade29
Project Khanya: results from a pilot randomized type 1 hybrid effectiveness‐implementation trial of a peer‐delivered behavioural intervention for ART adherence and substance use in HIV care in South A28
HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates28
Uptake and retention on HIV pre‐exposure prophylaxis among key and priority populations in South‐Central Uganda28
Stigma impedes HIV prevention by stifling patient–provider communication about U = U28
Estimating the contribution of key populations towards HIV transmission in South Africa28
Weight gain during the dolutegravir transition in the African Cohort Study28
Shifting the narrative: from “the missing men” to “we are missing the men”28
Early child development in children who are HIV‐exposed uninfected compared to children who are HIV‐unexposed: observational sub‐study of a cluster‐randomized trial in rural Zimbabwe28
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project26
Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa26
Evaluation of a pre‐exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens26
Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta‐analysis26
Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population‐based cross‐sectional behavioural surveillance studies26
Pathways for reduction of HIV‐related stigma: a model derived from longitudinal qualitative research in Kenya and Uganda25
HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project25
Directed and target focused multi‐sectoral adolescent HIV prevention: Insights from implementation of the ‘DREAMS Partnership’ in rural South Africa24
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review24
Mental health interventions for persons living with HIV in low‐ and middle‐income countries: a systematic review24
Interventions to address the mental health of adolescents and young adults living with or affected by HIV: state of the evidence24
Give the community the tools and they will help finish the job: key population‐led health services for ending AIDS in Thailand23
Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta‐analysis23
A call to improve understanding of Undetectable equals Untransmittable (U = U) in Brazil: a web‐based survey23
Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90‐90‐90 in sub‐Saharan Africa – a systematic review and meta‐analysis23
HIV self‐testing partially filled the HIV testing gap among men who have sex with men in China during the COVID‐19 pandemic: results from an online survey23
Twenty‐four‐month outcomes from a cluster‐randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs22
Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub‐Saharan Africa22
An open‐label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV preventio22
HIV infection and engagement in HIV care cascade among men who have sex with men and transgender women in Kigali, Rwanda: a cross‐sectional study22
Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a 22
Same‐day antiretroviral therapy is associated with increased loss to follow‐up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV22
Two years after lockdown: reviewing the effects of COVID‐19 on health services and support for adolescents living with HIV in South Africa21
Youth engagement in HIV prevention intervention research in sub‐Saharan Africa: a scoping review21
Adapting HIV services for pregnant and breastfeeding women, infants, children, adolescents and families in resource‐constrained settings during the COVID‐19 pandemic21
The impact of disruptions due to COVID‐19 on HIV transmission and control among men who have sex with men in China21
Men missing from the HIV care continuum in sub‐Saharan Africa: a meta‐analysis and meta‐synthesis21
Uncovering ART adherence inconsistencies: An assessment of sustained adherence among adolescents in South Africa20
Reproductive aspirations, contraception use and dual protection among adolescent girls and young women: the effect of motherhood and HIV status20
Impact of male circumcision on risk of HIV infection in men in a changing epidemic context – systematic review and meta‐analysis20
Long‐term virologic responses to antiretroviral therapy among HIV‐positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis20
Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia20
Attrition in HIV care following HIV diagnosis: a comparison of the pre‐UTT and UTT eras in South Africa20
“I just keep quiet about it and act as if everything is alright” – The cascade from trauma to disengagement among adolescents living with HIV in western Kenya20
Prevalence of nonsuppressed viral load and associated factors among HIV‐positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from 20
Association of age with healthcare needs and engagement among Nigerian men who have sex with men and transgender women: cross‐sectional and longitudinal analyses from an observational cohort19
Results from a difference‐in‐differences evaluation of health facility HIV and key population stigma‐reduction interventions in Ghana19
Updates to the Spectrum/AIM model for the UNAIDS 2020 HIV estimates19
HIV pre‐exposure prophylaxis for female sex workers: ensuring women’s family planning needs are not left behind19
Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study19
Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China19
Modelling impact and cost‐effectiveness of oral pre‐exposure prophylaxis in 13 low‐resource countries19
Reframing the approach to heterosexual men in the HIV epidemic in sub‐Saharan Africa19
Measuring linkage to HIV treatment services following HIV self‐testing in low‐income settings19
Intervening for HIV prevention and mental health: a review of global literature19
Overview of the epidemiological conditions of HIV among key populations in Africa19
Missed opportunities for sexually transmitted infections testing for HIV pre‐exposure prophylaxis users: a systematic review19
Intimate partner and client‐perpetrated violence are associated with reduced HIV pre‐exposure prophylaxis (PrEP) uptake, depression and generalized anxiety in a cross‐sectional study of female sex wor18
HIV prevalence, testing and treatment among men who have sex with men through engagement in virtual sexual networks in Kenya: a cross‐sectional bio‐behavioural study18
Male partner testing and sexual behaviour following provision of multiple HIV self‐tests to Kenyan women at higher risk of HIV infection in a cluster randomized trial18
“It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid‐1918
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies18
Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients18
Adherence to event‐driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3‐monthly questionnaires and intracellular TFV‐DP18
Creating HIV risk profiles for men in South Africa: a latent class approach using cross‐sectional survey data18
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead18
Fostering successful and sustainable collaborations to advance implementation science: the adolescent HIV prevention and treatment implementation science alliance18
Early access to antiretroviral therapy versus standard of care among HIV‐positive participants in Eswatini in the public health sector: the MaxART stepped‐wedge randomized controlled trial18
Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial18
Uptake and impact of facility‐based HIV self‐testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya18
Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa17
Point‐of‐care HIV maternal viral load and early infant diagnosis testing around time of delivery at tertiary obstetric units in South Africa: a prospective study of coverage, results return and turn‐a17
“Patients are not the same, so we cannot treat them the same” – A qualitative content analysis of provider, patient and implementer perspectives on differentiated service delivery models for HIV treat17
Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial17
Lottery incentives have short‐term impact on ART initiation among men: results from a randomized pilot study17
Preference for using a variety of future HIV pre‐exposure prophylaxis products among men who have sex with men in three US cities17
HIV prevention: better choice for better coverage17
Preference for daily versus on‐demand pre‐exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real‐world Oral PrEP Demonstration study17
Accelerating progress towards the elimination of mother‐to‐child transmission of HIV: a narrative review16
It’s not all about COVID‐19: pneumocystis pneumonia in the era of a respiratory outbreak16
Stigma and quality of co‐located care for HIV‐positive people in addiction treatment in Ukraine: a cross‐sectional study16
Imperfect adherence in real life: a prevention‐effective perspective on adherence to daily and event‐driven HIV pre‐exposure prophylaxis among men who have sex with men – a prospective cohort study in16
Intersecting stigma and HIV testing practices among urban refugee adolescents and youth in Kampala, Uganda: qualitative findings16
Broadly neutralizing monoclonal antibodies for HIV prevention16
HIV service delivery in the time of COVID‐19: focus group discussions with key populations in India16
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study16
Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID‐19 pandemic: descriptive analysis of programmatic data16
HIV self‐testing and oral pre‐exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda16
Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project16
Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12‐month cohort study in urban South Africa and rural Uganda15
Inclusion as illusion: erasing transgender women in research with MSM15
HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs15
Home‐Based Intervention to Test and Start (HITS): a community‐randomized controlled trial to increase HIV testing uptake among men in rural South Africa15
Integrating care for non‐communicable diseases into routine HIV services: key considerations for policy design in sub‐Saharan Africa15
Progress towards 2020 global HIV impact and treatment targets15
Can HIV recent infection surveillance help us better understand where primary prevention efforts should be targeted? Results of three pilots integrating a recent infection testing algorithm into routi15
Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study15
A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya15
Characteristics of the HIV cascade of care and unsuppressed viral load among gay, bisexual and other men who have sex with men living with HIV across Canada’s three largest cities14
The HIV care cascade in sub‐Saharan Africa: systematic review of published criteria and definitions14
Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled 14
Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic‐based observational cohort study in four African countries14
“Because we all have to grow up”: supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently14
Prospective assessment of loss to follow‐up: incidence and associated factors in a cohort of HIV‐positive adults in rural Tanzania14
High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional study14
Risk factors for loss to follow‐up among at‐risk HIV negative men who have sex with men participating in a research cohort with access to pre‐exposure prophylaxis in coastal Kenya14
Evidence of an untamed HIV epidemic among MSM and TGW in Rio de Janeiro, Brazil: a 2018 to 2020 cross‐sectional study using recent infection testing14
A one‐stop shop model for improved efficiency of pre‐exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study14
Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo14
Cost‐effectiveness analysis of integrating screening and treatment of selected non‐communicable diseases into HIV/AIDS treatment in Uganda14
Evaluation of near point‐of‐care viral load implementation in public health facilities across seven countries in sub‐Saharan Africa13
Key populations are the future of the African HIV/AIDS pandemic13
Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV13
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States13
Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice13
Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study13
Integrating HIV pre‐exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study13
Sexual behaviour change following HIV testing services: a systematic review and meta‐analysis13
Retention of a cohort of men who have sex with men and transgender women at risk for and living with HIV in Abuja and Lagos, Nigeria: a longitudinal analysis13
COVID‐19 vulnerability among people who use drugs: recommendations for global public health programmes and policies13
Point‐of‐care testing can achieve same‐day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries13
Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain13
The impact of the COVID‐19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review13
Healthcare worker training to improve quality of care for sexual and gender minority people in sub‐Saharan Africa: learning from efforts in Uganda13
Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda13
Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study13
Acceptability and feasibility of leveraging community‐based HIV counselling and testing platforms for same‐day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa12
Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibany12
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second‐line ART12
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study12
Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub‐Saharan Africa12
Community‐based differentiated service delivery models incorporating multi‐month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits:12
Determinants of suboptimal CD4+ T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection12
Acute and early HIV infection screening among men who have sex with men, a systematic review and meta‐analysis12
HIV PrEP is more than ART‐lite: Longitudinal study of real‐world PrEP services data identifies missing measures meaningful to HIV prevention programming12
Super learner analysis of real‐time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non‐differentiated care approaches for persons living 12
Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three‐arm cluster randomized controlled trial12
Examining the relationship between physical and sexual violence and psychosocial health in young people living with HIV in rural South Africa12
“You are not a man”: a multi‐method study of trans stigma and risk of HIV and sexually transmitted infections among trans men in Uganda12
Pharmacy delivery to expand the reach of PrEP in Africa12
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort12
Adopting U = U to end stigma and discrimination12
What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?12
Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness st11
Effects of behavioural interventions on postpartum retention and adherence among women with HIV on lifelong ART: the results of a cluster randomized trial in Kenya (the MOTIVATE trial)11
A review of HIV pre‐exposure prophylaxis (PrEP) programmes by delivery models in the Asia‐Pacific through the healthcare accessibility framework11
The search for an HIV vaccine, the journey continues11
Development and validation of the HIV adolescent readiness for transition scale (HARTS) in South Africa11
“We give them threatening advice…”: expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi11
Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis11
Using a mixed‐methods approach to adapt an HIV stigma reduction intervention to address intersectional stigma faced by men who have sex with men in Ghana11
HIV programmatic outcomes following implementation of the ‘Treat‐All’ policy in a public sector setting in Eswatini: a prospective cohort study11
Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background HIV incidence: a secondary analysis of a randomized, controlled trial11
Integrating mental health into HIV prevention and care: a call to action11
The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in sub‐Saharan Africa (HPTN 075)11
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment11
It is a question of equity: time to talk about children who are HIV‐exposed and “HIV‐free”11
What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis11
Comparison between daily and on‐demand PrEP (pre‐exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open‐label,11
Economic evaluation of facility‐based HIV self‐testing among adult outpatients in Malawi11
Evaluation of the integration of telehealth into the same‐day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID‐19: a mixed‐method analysis of real‐world data11
An evaluation of assumptions underlying respondent‐driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United States11
Patient‐reported reasons for declining same‐day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed‐effects regression analysis11
Does resource insecurity drive HIV‐related stigma? Associations between food and housing insecurity with HIV‐related stigma in cohort of women living with HIV in Canada11
Frameworks and measures for HIV‐related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review11
Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost‐effectiveness from a national and regional perspective10
Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa10
The efficacy and cost‐effectiveness of a family‐based economic empowerment intervention (Suubi + Adherence) on suppression of HIV viral loads among adolescents living with HIV: results from a Cluster 10
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study10
Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico10
Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide10
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana10
Involvement of African men and transgender women who have sex with men in HIV research: progress, but much more must be done10
Global scoping review of HIV prevention research with transgender people: Transcending from trans‐subsumed to trans‐centred research10
Prevalence of and factors associated with advanced HIV disease among newly diagnosed people living with HIV in Guangdong Province, China10
When healthcare providers are supportive, ‘I'd rather not test alone’: Exploring uptake and acceptability of HIV self‐testing for youth in Zimbabwe – A mixed method study10
0.045882940292358